Skip to main content
graph.swiss
Alcon Inc.

Alcon Inc.

56.70 CHF-0.24 (-0.42%)
XSWX:ALCMarket Closed
ListedCHF27.8BHealthcareMedical Instruments & Supplies25,000 employees

Company Profile

Legal NameAlcon Inc.
CEOMr. David J. Endicott
HeadquartersChemin de Blandonnet 8
Phone41 589 112 110
Employees (FTE)25,000
SectorHealthcare
IndustryMedical Instruments & Supplies

Business Description

Alcon Inc. is a leading global vision care company specializing in the development, manufacture, and marketing of surgical equipment, devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. Originally founded in 1945 and headquartered in Geneva, Switzerland, it operated as a subsidiary of Novartis for nine years before becoming an independent public company in April 2019. Alcon Inc. functions through two primary segments: Vision Care, which includes contact lenses, lens care solutions, and ocular health products under brands like Dailies, Total1, and Air Optix, capturing about one-fourth of the U.S. contact lens market; and Surgical, featuring intraocular lenses, ophthalmic surgical equipment, and consumables such as the Centurion phacoemulsification device for cataract surgeries and IOLs like PanOptix and Vivity. With approximately 25,599 employees, Alcon Inc. maintains one of the largest installed bases of eye surgical equipment worldwide, playing a pivotal role in the healthcare sector, particularly in medical instruments and supplies, by advancing eye health innovations and supporting ophthalmologists and consumers globally.

Profitability & Growth

Profitability

Profit Margin+7.70%
Operating Margin+12.20%
Return on Equity (TTM)+3.71%
Return on Assets (TTM)+2.54%

Recent Year-End

Revenue8.61B
Revenue / Share21.65
Gross Profit4.83B
EBITDA2.54B
Diluted EPS1.35
Earnings Growth YoY-46.00%
Revenue Growth YoY+9.40%

Balance Sheet Snapshot

Total Cash (MRQ)

1.34B

Total Debt (MRQ)

4.26B

Current Ratio (MRQ)

2.20

Book Value / Share

36.73

Stock Statistics

Shares Outstanding487.7M
Float Shares486.1M
Avg Volume (10d)1.4M
Avg Volume (90d)1.4M
% Held by Insiders+0.18%
% Held by Institutions+66.43%

Valuation

Market Cap27.77B
Enterprise Value24.31B
Trailing P/E40.16
Forward P/E15.21
PEG Ratio-0.89
Price / Sales (TTM)2.49
Price / Book (MRQ)1.48
EV / Revenue2.83
EV / EBITDA12.99

Price Summary

52-Week Low47.80
52-Week High74.34
50-Day MA52.92
200-Day MA59.58
Beta0.70

Dividends

Forward Div Rate1.12
Forward Div Yield+1.98%
Trailing Div Rate0.28
5Y Avg Div Yield+31.00%
Payout Ratio+20.39%
Dividend Date2025-05-15
Ex-Dividend Date2026-05-05